Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Garrison

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmacoeconomics - Open|December 17, 2024
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological ConsiderationsPraveen Thokala, Henrique Duarte, Stuart Wright, et al.
Diabetes, Obesity & Metabolism|August 26, 2025
Metrics that matter: Identifying endpoints for capturing the broad health impacts of prevention of obesityJonathan Pearson-Stuttard, Sara Holloway, Jamie Kettle, et al.
Diabetes, Obesity & Metabolism|November 5, 2025
A novel framework to assess the prevention value of a health interventionJonathan Pearson-Stuttard, Catrin Treharne, Robert King, et al.
Medical Care|January 26, 2012
Prioritization in comparative effectiveness research: the CANCERGEN ExperienceRahber Thariani, William Wong, Josh J Carlson, et al.
Public Health Genomics|July 23, 2019
The Value of Diagnostic Information in Personalised Healthcare: A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare SystemsVictoria Wurcel, Americo Cicchetti, Louis Garrison, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 15, 2020
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapiesDoug Coyle, Isabelle Durand-Zaleski, Jasmine Farrington, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmacoeconomics - Open|December 17, 2024
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological ConsiderationsPraveen Thokala, Henrique Duarte, Stuart Wright, et al.
Diabetes, Obesity & Metabolism|August 26, 2025
Metrics that matter: Identifying endpoints for capturing the broad health impacts of prevention of obesityJonathan Pearson-Stuttard, Sara Holloway, Jamie Kettle, et al.
Diabetes, Obesity & Metabolism|November 5, 2025
A novel framework to assess the prevention value of a health interventionJonathan Pearson-Stuttard, Catrin Treharne, Robert King, et al.
Medical Care|January 26, 2012
Prioritization in comparative effectiveness research: the CANCERGEN ExperienceRahber Thariani, William Wong, Josh J Carlson, et al.
Public Health Genomics|July 23, 2019
The Value of Diagnostic Information in Personalised Healthcare: A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare SystemsVictoria Wurcel, Americo Cicchetti, Louis Garrison, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 15, 2020
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapiesDoug Coyle, Isabelle Durand-Zaleski, Jasmine Farrington, et al.
Pageof 2